SIBN Stock Summary and Trading Ideas (Si-Bone | NASDAQ:SIBN)

SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Si-Bone trades on the NASDAQ stock market under the symbol SIBN.

As of April 10, 2026, SIBN stock price declined to $12.84 with 963,961 million shares trading.

SIBN has a beta of 0.71, meaning it tends to be less sensitive to market movements. SIBN has a correlation of 0.04 to the broad based SPY ETF.

SIBN has a market cap of $567.08 million. This is considered a Small Cap stock.

Last quarter Si-Bone reported $56 million in Revenue and -$.04 earnings per share. This beat revenue expectation by $73,400 and exceeded earnings estimates by $.09.

In the last 3 years, SIBN traded as high as $29.51 and as low as $11.70.

The top ETF exchange traded funds that SIBN belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

SIBN has underperformed the market in the last year with a price return of -3.1% while the SPY ETF gained +30.9%. SIBN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -37.2% and +4.5%, respectively, while the SPY returned -1.8% and +7.2%, respectively.

SIBN support price is $13.24 and resistance is $14.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SIBN shares will trade within this expected range on the day.